deltatrials
Completed EARLY_PHASE1 NCT01252979

Ketones & Mitochondrial Heteroplasmy

Sponsor: The University of Texas Health Science Center, Houston

Conditions MELAS Syndrome Mitochondrial Diseases
Interventions Medium-Chain Triglycerides
Updated 6 times since 2017 Last updated: Feb 3, 2012 Started: Dec 31, 2010 Primary completion: Dec 31, 2011 Completion: Dec 31, 2011

Listed as NCT01252979, this EARLY_PHASE1 trial focuses on MELAS Syndrome and Mitochondrial Diseases and remains completed. Sponsored by The University of Texas Health Science Center, Houston, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed EARLY_PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed EARLY_PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed EARLY_PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Completed EARLY_PHASE1

  5. Feb 2017 — Jun 2018 [monthly]

    Completed EARLY_PHASE1

    Phase: Phase 0 → EARLY_PHASE1

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Completed Phase 0

    First recorded

Dec 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • The University of Texas Health Science Center, Houston
Data source: The University of Texas Health Science Center, Houston

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Houston, United States